Accessibility Menu
Ambu A/s logo

Ambu A/s(OTC) AMBBY

Market Cap$2.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-16%
5 Year-66%
1 Year-27%
1 Month+1%
$11.00
+4.66%
+0.49Today
Ambu A/s last closing stock price
MetricPriceDate
Last closeUSD 11.002026-09-03
Ambu A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.66%USD 10.512026-08-27
1 month+1.29%USD 10.862026-07-28
3 month+8.21%USD 10.172026-06-03
Year to date-16.67%USD 13.202025-12-31
1 year-26.52%USD 14.972025-09-03
3 year-8.08%USD 11.972023-09-01
5 year-66.41%USD 32.752021-09-03
Since inception-15.71%USD 13.052017-07-31

Ambu A/s Financials at a Glance

Market Cap

$2.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-DKK 18.58B

Net Income (TTM)

DKK 514.31M

EPS (TTM)

$0.30

P/E Ratio

36.88

Dividend

$0.06

Beta (Volatility)

0.52 (Low)

Price

$11.00

Volume

60

Open

$11.00

Previous Close

$11.00

Daily Range

$11.00 - $11.00

52-Week Range

$8.55 - $16.78

Estimated Earnings Date

Aug 21, 2024

AMBBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ambu A/s

Ambu A/S is a leading developer and manufacturer of diagnostic and life-supporting devices for hospitals and rescue services. Founded in 1937 and headquartered in Ballerup, Denmark, the company operates in three segments: Anaesthesia, Patient Monitoring & Diagnostics, and Visualisation.

Products and Services
  • Resuscitators, face masks, and laryngeal masks in the Anaesthesia segment
  • Electrodes for cardiology and neurophysiology in Patient Monitoring & Diagnostics
  • Single-use visualisation devices for bronchoscopy procedures in the Visualisation segment
Growth Outlook
  • Revenue increased to DKK 1.67 billion in Q3 2026, reflecting strong demand
  • Operating income margin improved to 13.5% in the latest quarter
  • Continued investment in R&D, with expenses of DKK 88.5 million in Q3 2026
Financial Highlights
  • Net income of DKK 158.7 million reported for Q3 2026
  • Gross profit margin of 59.4% in the latest quarter
  • Current ratio of 2.77 indicates strong liquidity position
Ambu A/S has established itself as a key player in the medical devices industry, focusing on innovative solutions that enhance patient care. The company's diverse product offerings cater to critical healthcare needs, positioning it well for future growth. Recent financial performance demonstrates resilience, with significant revenue growth and improved profitability metrics. The commitment to research and development underscores Ambu's strategy to maintain a competitive edge in a rapidly evolving market. With a solid financial foundation and a focus on innovation, Ambu A/S presents an intriguing opportunity for potential investors interested in the healthcare sector.
AI Generated • Aug 31, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,384

CEO

Britt Meelby Jensen, MBA

Website

www.ambu.com

Headquarters

Ballerup, CR 2750, DK

AMBBY Financials

Key Financial Metrics (TTM)

Gross Margin

56.04%

Operating Margin

11.30%

Net Income Margin

8.18%

Return on Equity

8.38%

Return on Capital

11.20%

Return on Assets

6.56%

Earnings Yield

2.71%

Dividend Yield

0.58%

Payout Ratio

21.37%

Stock Overview

Market Cap

$2.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

232.24M

Volume

60

Avg. Volume

191.641

Financials (TTM)

Gross Profit

-DKK 11.45B

Operating Income

DKK 711.20M

EBITDA

DKK 1.11B

Operating Cash Flow

DKK 955.80M

Capital Expenditure

-DKK 206.38M

Free Cash Flow

DKK 749.71M

Cash & ST Invst.

DKK 705.04M

Total Debt

DKK 579.03M

Ambu A/s Performance Analysis

Ambu A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30DKK 646,011,7000.2%
20232023-09-30DKK 683,534,3945.8%
20242024-09-30DKK 783,483,30914.6%
20252025-09-30DKK 893,338,34914.0%
Ambu A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-1653.4%
Q12025-12-31106.7%
Q22026-03-312.6%
Q32026-06-304.3%
Ambu A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30DKK 0.05-66.1%
20232023-09-30DKK 0.0973.8%
20242024-09-30DKK 0.1338.8%
20252025-09-30DKK 0.34163.5%
Ambu A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-6.5%
Q12025-12-312.3%
Q22026-03-314.5%
Q32026-06-3030.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

DKK 1.67B

+10.7%

Gross Profit

DKK 991.81M

+11.8%

Gross Margin

59.45%

N/A

Market Cap

$2.55BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$474.48K

N/A

Employees

5,384

N/A

Net Income

DKK 158.69M

+29.0%

EBITDA

DKK 326.53M

+22.8%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

DKK 705.04M

-6.1%

Total Debt

DKK 579.03M

+8.4%

Accounts Receivable

DKK 1.05B

+18.6%

Inventory

DKK 1.20B

+0.8%

Long Term Debt

DKK 492.02M

+7.2%

Short Term Debt

DKK 87.00M

+0.2%

Return on Assets

6.56%

N/A

Return on Invested Capital

10.57%

N/A

Free Cash Flow

DKK 261.42M

+104.2%

Operating Cash Flow

DKK 339.33M

+43.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMFPFAmplifon S.p.A.
$11.21+0.00%
NHNKYNihon Kohden Corporation
$9.76+2.63%
CZMWYCarl Zeiss Meditec AG
$37.33-1.63%
CZMWFCarl Zeiss Meditec AG
$39.96+9.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About AMBBY

What is the current price of Ambu A/s?

Ambu A/s is trading at $11.00 per share.

What is the 52-week range for Ambu A/s?

Over the past 52 weeks, Ambu A/s has traded between $8.55 and $16.78.

How much debt does Ambu A/s have?

As of the most recent reporting period, Ambu A/s reported total debt of DKK 88.56M.

How much cash does Ambu A/s have on hand?

Ambu A/s reported DKK 107.83M in cash and cash equivalents in its most recent financial results.

What is Ambu A/s’s dividend yield?

Ambu A/s currently has a dividend yield of 0.58%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services